SSCGX
Price
$30.70
Change
+$0.55 (+1.82%)
Updated
Apr 23 closing price
Net Assets
243.41M
VEXRX
Price
$92.56
Change
+$1.44 (+1.58%)
Updated
Apr 23 closing price
Net Assets
19.79B
Ad is loading...

SSCGX vs VEXRX

Header iconSSCGX vs VEXRX Comparison
Open Charts SSCGX vs VEXRXBanner chart's image
SEI Small Cap Growth F (SIMT)
Price$30.70
Change+$0.55 (+1.82%)
VolumeN/A
Net Assets243.41M
Vanguard Explorer Adm
Price$92.56
Change+$1.44 (+1.58%)
VolumeN/A
Net Assets19.79B
SSCGX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SSCGX vs. VEXRX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SSCGX is a Buy and VEXRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.8B vs. SSCGX (243M). VEXRX pays higher dividends than SSCGX: VEXRX (0.56) vs SSCGX (0.06). SSCGX was incepted earlier than VEXRX: SSCGX (33 years) vs VEXRX (23 years). SSCGX (1.23) is less costly to investors than VEXRX (0.34). SSCGX is a more actively managed with annual turnover of: 192.00 vs. VEXRX (35.00). VEXRX has a lower initial minimum investment than SSCGX: VEXRX (50000) vs SSCGX (100000). SSCGX annual gain was more profitable for investors over the last year : -10.09 vs. VEXRX (-12.82). SSCGX return over 5 years is better than : 18.40 vs. VEXRX (15.80).
SSCGXVEXRXSSCGX / VEXRX
Total Expense Ratio1.110.34326%
Annual Report Gross Expense Ratio1.230.34362%
Fund Existence33 years23 years-
Gain YTD-15.214-14.722103%
Front LoadN/AN/A-
Min. Initial Investment10000050000200%
Min. Initial Investment IRAN/AN/A-
Net Assets243M19.8B1%
Annual Yield % from dividends0.060.5610%
Returns for 1 year-10.09-12.8279%
Returns for 3 years-5.54-9.4059%
Returns for 5 years18.4015.80116%
Returns for 10 years-0.66-1.7637%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XBI79.101.46
+1.88%
SPDR® S&P Biotech ETF
CHI9.780.17
+1.77%
Calamos Convertible Opportunities and Income Fund
SBIO28.020.45
+1.63%
ALPS Medical Breakthroughs ETF
BCDF28.540.12
+0.44%
Horizon Kinetics Blockchain Dev ETF
FEP41.67-0.06
-0.14%
First Trust Europe AlphaDEX® ETF